Gene expression biomarkers of response to citalopram treatment in major depressive disorder

There is significant variability in antidepressant treatment outcome, with ∼30–40% of patients with major depressive disorder (MDD) not presenting with adequate response even following several trials. To identify potential biomarkers of response, we investigated peripheral gene expression patterns o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamdani, F, Berlim, M T, Beaulieu, M-M, Labbe, A, Merette, C, Turecki, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309465/
https://www.ncbi.nlm.nih.gov/pubmed/22832429
http://dx.doi.org/10.1038/tp.2011.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3309465/
https://www.ncbi.nlm.nih.gov/pubmed/22832429
http://dx.doi.org/10.1038/tp.2011.12

Ejemplares similares